CASI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.63	13.47	17.08	47.11	38.7
Short-Term Investments	-	2.62	13.69	4.23	9.87
Cash & Short-Term Investments	5.63	16.09	30.77	51.34	48.57
Cash Growth	-65.00%	-47.70%	-40.06%	5.69%	-26.82%
Accounts Receivable	4.09	15.35	9.55	12.97	9.8
Other Receivables	-	-	0.59	-	-
Receivables	4.09	15.35	10.14	12.97	9.8
Inventory	1.6	5.25	15.88	6.14	1.91
Prepaid Expenses	2.14	2.89	2.56	2.98	1.69
Total Current Assets	13.46	39.58	59.34	73.42	61.97
Property, Plant & Equipment	9.52	11.36	11.63	13.23	21.82
Long-Term Investments	1.72	1.91	1.69	7.46	40.13
Other Intangible Assets	0.22	0.24	1.84	1.06	12.2
Other Long-Term Assets	0.74	0.59	0.77	1.06	2.18
Total Assets	25.65	53.67	75.27	96.23	138.3
Accounts Payable	1.07	2.72	4.44	3.29	2.22
Accrued Expenses	13.9	8.47	7.15	7.64	6.04
Short-Term Debt	1	-	-	-	-
Current Portion of Long-Term Debt	23.43	18.39	-	-	-
Current Portion of Leases	1.61	1.22	0.73	0.87	1.06
Current Income Taxes Payable	-	-	-	1.9	-
Current Unearned Revenue	2.58	2.47	2.54	2.62	0.06
Other Current Liabilities	6.08	3.18	1.87	0.69	3.81
Total Current Liabilities	49.67	36.45	16.73	17.01	13.19
Long-Term Debt	-	-	18.9	-	-
Long-Term Leases	1.44	2.54	1.62	0.48	1.11
Long-Term Unearned Revenue	-	-	-	-	2.83
Other Long-Term Liabilities	11.82	12.84	13.87	11.82	13.22
Total Liabilities	62.93	51.82	51.1	29.3	30.34
Common Stock	0	0	0	0	0
Additional Paid-In Capital	722.24	713.3	695.79	691.77	696.22
Retained Earnings	-748.13	-700.08	-660.82	-637.16	-605.64
Treasury Stock	-9.6	-9.6	-9.6	-9.33	-8.03
Comprehensive Income & Other	-1.79	-1.77	-1.2	-0.7	1.95
Total Common Equity	-37.28	1.85	24.17	44.57	84.5
Minority Interest	-	-	-	22.36	23.46
Shareholders' Equity	-37.28	1.85	24.17	66.93	107.96
Total Liabilities & Equity	25.65	53.67	75.27	96.23	138.3
Total Debt	27.49	22.14	21.24	1.34	2.17
Net Cash (Debt)	-21.85	-6.05	9.53	49.99	46.41
Net Cash Growth	-	-	-80.94%	7.73%	-26.55%
Net Cash Per Share	-1.18	-0.39	0.71	3.66	3.41
Filing Date Shares Outstanding	20.56	15.49	12.99	13.32	13.66
Total Common Shares Outstanding	20.56	15.49	13.38	13.46	13.98
Working Capital	-36.21	3.12	42.62	56.42	48.78
Book Value Per Share	-1.81	0.12	1.81	3.31	6.04
Tangible Book Value	-37.5	1.61	22.33	43.51	72.3
Tangible Book Value Per Share	-1.82	0.10	1.67	3.23	5.17
Machinery	6.77	6.58	6.68	1.24	1.73
Construction In Progress	-	-	0.02	5.73	12.1
Leasehold Improvements	7.29	7	7.19	7.16	1.13